141 related articles for article (PubMed ID: 11917218)
1. Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?
Seidman JD; Sherman ME; Bell KA; Katabuchi H; O'Leary TJ; Kurman RJ
Int J Gynecol Pathol; 2002 Apr; 21(2):101-7. PubMed ID: 11917218
[TBL] [Abstract][Full Text] [Related]
2. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
[TBL] [Abstract][Full Text] [Related]
3. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal involvement by salpingoliths clinical significance and cytological challenges of interpretation.
El Hussein S; Guerrero D; Khader SN
Diagn Cytopathol; 2019 Dec; 47(12):1302-1305. PubMed ID: 31390157
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.
Smith Sehdev AE; Sehdev PS; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):725-36. PubMed ID: 12766576
[TBL] [Abstract][Full Text] [Related]
6. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas.
Staebler A; Heselmeyer-Haddad K; Bell K; Riopel M; Perlman E; Ried T; Kurman RJ
Hum Pathol; 2002 Jan; 33(1):47-59. PubMed ID: 11823973
[TBL] [Abstract][Full Text] [Related]
7. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
[TBL] [Abstract][Full Text] [Related]
8. Salpingitis in ovarian endometriosis.
Czernobilsky B; Silverstein A
Fertil Steril; 1978 Jul; 30(1):45-9. PubMed ID: 680183
[TBL] [Abstract][Full Text] [Related]
9. Incidental Serous Tubal Intraepithelial Carcinoma and Non-Neoplastic Conditions of the Fallopian Tubes in Grossly Normal Adnexa: A Clinicopathologic Study of 388 Completely Embedded Cases.
Seidman JD; Krishnan J; Yemelyanova A; Vang R
Int J Gynecol Pathol; 2016 Sep; 35(5):423-9. PubMed ID: 26630221
[TBL] [Abstract][Full Text] [Related]
10. Frequency of papillary tubal hyperplasia (PTH), salpingoliths and transition from adenoma to borderline ovarian tumors (BOT): A systematic analysis of 74 BOT with different histologic types.
Horn LC; Angermann K; Hentschel B; Einenkel J; Höhn AK
Pathol Res Pract; 2017 Apr; 213(4):305-309. PubMed ID: 28238382
[TBL] [Abstract][Full Text] [Related]
11. A small organ takes center stage: selected topics in fallopian tube pathology.
Rutgers JK; Lawrence WD
Int J Gynecol Pathol; 2014 Jul; 33(4):385-92. PubMed ID: 24901398
[TBL] [Abstract][Full Text] [Related]
12. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Vang R; Shih IeM; Kurman RJ
Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
[TBL] [Abstract][Full Text] [Related]
13. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Seidman JD; Kurman RJ
Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
[TBL] [Abstract][Full Text] [Related]
14. Xanthogranulomatous salpingitis associated with fallopian tube mucosal endometriosis: a clue to the pathogenesis.
Idrees M; Zakashansky K; Kalir T
Ann Diagn Pathol; 2007 Apr; 11(2):117-21. PubMed ID: 17349571
[TBL] [Abstract][Full Text] [Related]
15. Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential?
Yanai-Inbar I; Siriaunkgul S; Silverberg SG
Int J Gynecol Pathol; 1995 Apr; 14(2):107-13. PubMed ID: 8601521
[TBL] [Abstract][Full Text] [Related]
16. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
17. Pseudoxanthomatous salpingitis as an ex vivo model of fallopian tube serous carcinogenesis: a clinicopathologic study of 49 cases.
Seidman JD; Woodburn R
Int J Gynecol Pathol; 2015 May; 34(3):275-80. PubMed ID: 25760905
[TBL] [Abstract][Full Text] [Related]
18. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.
Seidman JD; Kurman RJ
Am J Surg Pathol; 1996 Nov; 20(11):1331-45. PubMed ID: 8898837
[TBL] [Abstract][Full Text] [Related]
19. Diverse tumorigenic pathways in ovarian serous carcinoma.
Singer G; Kurman RJ; Chang HW; Cho SK; Shih IeM
Am J Pathol; 2002 Apr; 160(4):1223-8. PubMed ID: 11943707
[TBL] [Abstract][Full Text] [Related]
20. The presence of mucosal iron in the fallopian tube supports the "incessant menstruation hypothesis" for ovarian carcinoma.
Seidman JD
Int J Gynecol Pathol; 2013 Sep; 32(5):454-8. PubMed ID: 23896711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
